I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Sagimet Biosciences (SGMT). The reason why I want to go over this biotech next is because just ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is part of a new ...

SAN FRANCISCO -- - Left-hander Sam Hentges and the San Francisco Giants agreed to a $1.4 million, one-year contract and hope he will be healthy for the start of spring training in two months. The team ...

The European Space Agency (ESA) has completed the service module for NASA's Orion spaceship, which is meant to take the nearly cancelled Artemis 4 mission to the moon. The module, which is supposed to ...

Rarely has a month gone by in 2025 without OpenAI signing another multibillion-dollar data center deal. In a lengthy post on X on Thursday, OpenAI CEO Sam Altman publicly clarified the totals. “We ...

Saoirse Ronan, Aimee Lou Wood, Anna Sawai and Mia McKenna-Bruce are confirmed to star in Sony Pictures, Sam Mendes and Neal Street’s “The Beatles — A Four-Film Cinematic Event,” the studio announced ...

Pfizer has thrown money at its obesity R&D problem. Having seen its internal assets flounder, the Big Pharma has struck a deal to buy Metsera for an initial $4.9 billion to secure a pipeline of ...

Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what’s been a flurry of acquisitions at a similar price point. Novartis said it was purchasing ...

Novartis AG agreed to buy Tourmaline Bio Inc. in a deal valued at about $1.4 billion as the Swiss drugmaker continues to pursue bolt-on deals to boost its drug pipeline. The company will pay $48 per ...

Welcome to the FourThirdsEye project, an open-source camera board designed for Raspberry Pi 5 and Raspberry Pi Compute Module 4 boards using a Micro Four Thirds format image sensor IMX294. This ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min "This is not going to be the ...

New data from HSBC Innovation Banking add further evidence venture capital funding for private biotechnology companies has slid lower as the year has progressed, erasing what was a fast start to 2025.